US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 0.501
  • -0.043-7.92%
Close Mar 10 16:00 ET
  • 0.567
  • +0.065+13.03%
Pre 04:16 ET
62.47MMarket Cap-0.90P/E (TTM)

About Mersana Therapeutics Company

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.

Company Profile

SymbolMRSN
Company NameMersana Therapeutics
Listing DateJun 28, 2017
Issue Price15.00
Founded2001
CEODr. Martin H. Huber, M.D.
MarketNASDAQ
Employees102
Fiscal Year Ends12-31
Address840 Memorial Drive
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-498-0020
Websitehttp://www.mersana.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Martin H. Huber, M.D.
  • Director, President and Chief Executive Officer
  • 2.60M
  • Dr. Timothy B. Lowinger, PhD
  • Senior Vice President, Chief Science and Technology Officer
  • 1.69M
  • Alejandra Carvajal
  • Senior Vice President and Chief Legal Officer
  • 1.61M
  • Mohan Bala
  • Senior Vice President and Chief Development Officer
  • 1.58M
  • Dr. Tushar Misra, PhD
  • Senior Vice President and Chief Manufacturing Officer
  • --
  • Brian DeSchuytner
  • Senior Vice President, Chief Operating Officer and Chief Financial Officer
  • 1.74M
  • Ashish Mandelia
  • Vice President, Controller and Principal Accounting Officer
  • --
  • David M. Mott
  • Chairman of the Board
  • 329.93K
  • Anna Protopapas
  • Director
  • 4.45M
  • Allene M. Diaz
  • Independent Director
  • 294.93K
  • Lawrence M. Alleva
  • Independent Director
  • 308.93K
  • Dr. Andrew A. F. Hack, M.D.,PhD
  • Independent Director
  • 297.43K
  • Dr. Kristen M. Hege, M.D.
  • Independent Director
  • 293.43K
  • Dr. Willard H. Dere, M.D.
  • Independent Director
  • 305.43K
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Lantheus
LNTH
+3.45%
Collegium Pharmaceutical
COLL
+2.59%
Constellation Brands
STZ
+1.73%
Halozyme Therapeutics
HALO
+0.75%
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
0.00%

Unlock the Full List